Innovation
into.blood
Developing
therapies.for
the.treatment
of.rare.diseases
Our Technology
EryDel’s proprietary platform technology is an easy to use, fast and automatic bedside procedure, to encapsulate small and large molecules including therapeutic enzymes in patients’ red blood cells. The cells are immediately re-infused into patients providing prolonged half-life in circulation, reduced immunogenicity, better tolerability and predictable vascular distribution.
DiscoverA late Stage
and Broad Pipeline
More details
